| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/02/2013 | CN103333256A Human acid fibroblast growth factor fusion protein, and coding gene and applications thereof |
| 10/02/2013 | CN103333255A Long-acting HIV-1 (Human Immunodeficiency Virus-1) membrane fusion inhibitor |
| 10/02/2013 | CN103333254A Purifying method of methicillin-resistant staphylococcus aureus MRSA recombinant protein vaccine I1C |
| 10/02/2013 | CN103333253A Nano antibody fusion protein, and preparation method and application thereof |
| 10/02/2013 | CN103333252A Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 10/02/2013 | CN103333251A Gamma-interferon sandwich ELISA detection method based on recombinant fusion antigen protein |
| 10/02/2013 | CN103333244A hZimp10 N-terminal high titer antibody prepared by using GST expression system and applications thereof |
| 10/02/2013 | CN103333236A Excellent winter sport athlete angiotensin converting enzyme partial polypeptide polyclonal antibody preparation method |
| 10/02/2013 | CN102603898B Fowl adenovirus group I immunity related fusion protein as well as encoding gene and application thereof |
| 10/02/2013 | CN102258773B Mesylate protein kinase receptor EphA2 dominant epitope compound and preparation method and application thereof |
| 10/01/2013 | US8545850 Anti-CD79B antibodies and immunoconjugates and methods of use |
| 10/01/2013 | CA2502304C Phenolic binding peptides |
| 09/26/2013 | WO2013142859A2 Fusion proteins of superfolder green fluorescent protein and use thereof |
| 09/26/2013 | WO2013139789A1 B-cell receptor complex binding proteins containing t-cell epitopes |
| 09/26/2013 | WO2013138850A1 Method of producing a recombinant peptide |
| 09/25/2013 | EP2640377A1 Fgfr1 extracellular domain combination therapies |
| 09/25/2013 | CN103328514A Protein complexes for antigen binding and methods of use |
| 09/25/2013 | CN103320459A Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 09/25/2013 | CN103320457A Plant oil body containing CoQ10 |
| 09/25/2013 | CN103320449A Allium chinensis lectin gene with anti-tumor activity and application of coding protein thereof |
| 09/25/2013 | CN103319610A Novel recombinant fusion protein, preparation method and use thereof |
| 09/25/2013 | CN103319609A Human basic fibroblast growth factor (hbFGF) fusion gene and application thereof |
| 09/25/2013 | CN103319608A Pig IFNalpha1-Fc fusion protein as well as encoding gene and expression method thereof |
| 09/25/2013 | CN103319607A CBM fragment and application thereof in specific binding of plant-source crystallized cellulose |
| 09/25/2013 | CN103319606A Liver targeted peptide-recombinant human endostatin fusion protein, and preparation method and application thereof |
| 09/25/2013 | CN103319605A Hepatic targeting peptide and angiogenesis inhibitor fusion protein as well as preparation method and application thereof |
| 09/25/2013 | CN103319604A Human rotavirus Delta VP8* subunit recombinant protein and application thereof |
| 09/25/2013 | CN103319603A Application of rice transcription factor Os01g64730 gene |
| 09/25/2013 | CN103319602A 疫苗载体 Vaccine vector |
| 09/25/2013 | CN103319601A 疫苗载体 Vaccine vector |
| 09/25/2013 | CN103319595A Preparation method and application of anti-human alpha fetoprotein (AFP) single-chain antibody and fusion antigen peptide |
| 09/25/2013 | CN102614506B Recombinant HPV16L2 protein vaccine and preparation method thereof |
| 09/24/2013 | CA2486583C Marker molecules associated with lung tumors |
| 09/24/2013 | CA2448427C Molecules and methods for inhibiting shedding of kim-1 |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/19/2013 | WO2013138795A1 Cell penetrating compositions for delivery of intracellular antibodies and antibody-like moieties and methods of use |
| 09/19/2013 | WO2013138484A1 Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin |
| 09/19/2013 | WO2013135103A1 Polypeptide carrying melittin, nanoparticle carrying melittin and use thereof |
| 09/19/2013 | WO2013134881A1 Generating targeted sequence diversity in fusion proteins |
| 09/19/2013 | US20130244239 Nucleic acid construct and complex formation method and screening method using the same |
| 09/19/2013 | US20130243769 Induced internalization of surface receptors |
| 09/19/2013 | US20130243768 Multimeric proteins and methods of making and using same |
| 09/18/2013 | EP2638073A2 Protein complexes for antigen binding and methods of use |
| 09/18/2013 | EP2638061A1 Soluble pd-1 variants, fusion constructs, and uses thereof |
| 09/18/2013 | CN103314012A Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
| 09/18/2013 | CN103304671A Human rotavirus P[8]deltaVP8*-P[6]deltaVP8* recombinant chimeric protein and application thereof |
| 09/18/2013 | CN103304670A Mycobacterium tuberculosis specific fusion protein vaccine AB and preparation and application thereof |
| 09/18/2013 | CN103304669A Humanization tumor immune cell cytokines TNTIL2 as well as preparation method and application thereof |
| 09/18/2013 | CN103304668A Ultra-VEGF-trap immune fusion protein, its preparation method and application |
| 09/18/2013 | CN103304646A Mycobacterium tuberculosis candidate antigen polypeptide and application thereof |
| 09/18/2013 | CN103304637A Cell permeable peptide hPP3 and usage thereof |
| 09/18/2013 | CN102676563B Method for preparing human serum albumin-human parathyroid hormone |
| 09/18/2013 | CN102492043B Anti-tumor and thrombolytic dual-effect chimeric protein with low immunogenicity, its preparation method and application |
| 09/18/2013 | CN101824091B G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof |
| 09/18/2013 | CN101665537B Novel apoptosis test regent and related kit |
| 09/18/2013 | CN101421306B Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 09/17/2013 | US8535681 Sustained drug delivery system |
| 09/17/2013 | CA2562711C Cab molecules |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/12/2013 | WO2013134656A1 Induction of th17 immune response |
| 09/12/2013 | WO2013133659A1 An improved process for preparation of physiologically active polypeptide complex |
| 09/12/2013 | WO2013133643A1 Fusion protein for activating rtk signal transmission by means of light, and use thereof |
| 09/12/2013 | US20130236469 Vaccine against streptococcal infections based on recombinant proteins |
| 09/11/2013 | EP2635593A1 Vaccines for preventing meningococcal infections |
| 09/11/2013 | CN103288968A An anti-tumor targeting complex and a preparation method and applications thereof |
| 09/11/2013 | CN103288967A Establishment and expression of fusion protein having function of adsorbing heavy metal ions, and application fusion protein in bioremediation |
| 09/11/2013 | CN103288966A Fusion receptor and gene medicine thereof for treating colorectal cancer |
| 09/11/2013 | CN103288935A Polypeptides |
| 09/11/2013 | CN102827292B Fusion protein TgMEP as well as preparation method and application thereof |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8530189 Sustained drug delivery system |
| 09/10/2013 | CA2693296C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/10/2013 | CA2673477C Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2392527C Hbv/hcv virus-like particle |
| 09/06/2013 | WO2013131091A1 Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders |
| 09/06/2013 | WO2013106643A3 Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase |
| 09/06/2013 | WO2013078564A3 Targeted lysosomal enzyme compounds |
| 09/06/2013 | WO2013078562A3 Targeted iduronate-2-sulfatase compounds |
| 09/05/2013 | US20130232588 Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System |
| 09/05/2013 | US20130231464 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 09/05/2013 | US20130231274 Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
| 09/05/2013 | US20130230855 Monocyte-derived Nucleic Acids and Related Compositions and Methods |
| 09/05/2013 | US20130230526 Klebsiella antigens |
| 09/05/2013 | US20130230522 Complement Pathway Inhibitors Binding To C5 and C5A Without Preventing The Formation of C5B |
| 09/05/2013 | US20130230515 Myostatin binding agents |
| 09/05/2013 | US20130230465 Benzocyanine compounds |
| 09/04/2013 | EP2632942A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same |
| 09/04/2013 | CN1622995B Receptor nucleic acids and polypeptides |
| 09/04/2013 | CN103282380A Erythrocyte-binding therapeutics |
| 09/04/2013 | CN103282379A Nd2 peptides and methods of treating neurological disease |
| 09/04/2013 | CN103276002A Oil body containing oil body protein and collagen fusion protein |
| 09/04/2013 | CN103275980A Antibodies, fusion protein and composition |
| 09/04/2013 | CN103275914A Bacterial ghost presenting protective antigens and application thereof |
| 09/04/2013 | CN103275912A Enterohemorrhagic Escherichia coli (EHEC) O157:H7 multivalent fliC-hcpA-tir-eae recombinant bacteria and vaccines |
| 09/04/2013 | CN103275228A K99-987P-F41 recombinant protein and application thereof |
| 09/04/2013 | CN103275220A The ED-A antigen of fibrinogen associated with the neovasculature of tumour metastases |
| 09/04/2013 | CN103272227A Peptides for desensibilization against allergens |
| 09/04/2013 | CN102406929B Co-expressed molecular adjuvant enhanced divalent foot and mouth disease protein engineering vaccine |
| 09/03/2013 | US8524868 Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits |